Failure Mode Effects Analysis (FMEA) is a proactive approach to assessing risk in organizations. The Utah Patient Safety Steering Committee's Adverse Drug Effects (ADE) User Group utilized this technique to identify methods to proactively prevent harm to patients from anticoagulant usage within health organizations. Hospitals and health systems can use the provided materials in several effective ways.

Suggestions for effectively utilizing the Utah ADE group's generated FMEA tools in your organization:

• Review executive summary to see if key actions are applicable.
• Review the included FMEA table to assess organizational implementation strategies in order to prevent harm to patients.
• Utilizing the tools below, conduct a FMEA specific to your organization, identifying mechanisms to prevent future harm.
  
  

FMEA Project on High Risk Drugs - Inpatient Anticoagulant Agents -- January 2005

Executive Summary

Flowchart

Failure Mode Effect Analysis Table (FMEA)

Appendices:

Key Literature

Anticoagulant Web sites& Patient Education Web sites

Heparins: Comparing Unfractionated & Low Molecular Weight Heparins

Anticoagulant Agent Use Checklist

Empty FMEA Worksheets:

• Excel Version
• PDF Version

User Group Participants

 

New:

WebEx Presentation from June 21st, 2005

 

For more information contact:

Group Chair: Linda.Tyler@hsc.utah.edu

UHA Contact: Scott@uha-utah.org